Dätwyler Holding AG
0QNJ.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.22B
Close$
$56.24
56.7% downside
Current Fair Value
56.7% downsideOvervalued by 56.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.22 Billion |
|---|---|
| Enterprise Value | $2.64 Billion |
| Dividend Yield | $3.20 (2.45%) |
| Earnings per Share | $4.75 |
| Beta | 1.08 |
| Outstanding Shares | 17,012,987 |
Return
| Return on Equity | 34.52% |
|---|---|
| Return on Assets | 10.10% |
| Return on Invested Capital | 20.83% |
Valuation & Multiples
| P/E Ratio | 27.04 |
|---|---|
| PEG | 731.99 |
| Price to Sales | 1.0 |
| Price to Book Ratio | 6.5 |
| Enterprise Value to Revenue | 1.19 |
| Enterprise Value to EBIT | 14.14 |
| Enterprise Value to Net Income | 23 |
| Total Debt to Enterprise | 0.19 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
July 23, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Daetwyler Holding AG
7,823 employees
CEO: Volker Cwielong Dätwyler Holding AG engages in the provision of supply of system-critical elastomer components for injectable drug delivery systems. It operates through the Healthcare Solutions and Industrial Solutions segments. The Healthcare Solutions...